Articles related to Ophthalmology

“We are recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift.”

Medication-induced ocular complications can occur across multiple drug classes, with risk factors including dosage, duration of treatment, and individual patient susceptibility.

Diabetic retinopathy is the only leading cause of blindness that has not experienced a decrease in age-standardized prevalence between 1990 and 2020, highlighting the urgent need for improved prevention and management strategies.

A formulation of over-the-counter antioxidant supplements reduced the progression of geographic atrophy, an advanced form of dry age-related macular degeneration, by 55% over three years compared to placebo.

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

Autonomous AI at the point of care significantly increases diabetic retinopathy screening rates among young patients, addressing access gaps in underserved communities and offering a practical solution to improve patient outcomes.